Ocular manifestations of SLE are common and may lead to permanent blindness from the underlying disease or therapeutic side effects. Keratoconjunctivitis sicca is the most common manifestation.

Treatments for these skin manifestations depend on grading. Inflammatory reaction that affects the quality of life or is grade ≥ 2 should be considered as an indication to hold the ICI and monitor ...